Sale of 3,270 shares at $205.8075 per share.
Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-09-15. https://desqlong.com/cards/0001462808-26-000007-10 (retrieved 2026-09-26).